One of the most important things you can do to align healthcare strategies in the shift toward value-based care is to allow your clinicians to be part of that journey, explained Jason Mitchell, MD, chief medical and clinical transformation officer, Presbyterian Healthcare Services.
One of the most important things you can do to align healthcare strategies in the shift toward value-based care is to allow your clinicians to be part of that journey, explained Jason Mitchell, MD, chief medical and clinical transformation officer, Presbyterian Healthcare Services.
Transcript
What are some potential strategies for aligning incentives across the entire healthcare system during the shift to value-based care?
I think one of the most important things you can do to align healthcare strategies is to allow your clinicians to be part of that journey. Get your physicians, your nurses, your pharmacists, everybody involved upfront so they can recognize the connection to the care and they can help you understand what you should be doing. The other thing is to make sure your leaders are aligned. As you think about budgets and operating margins, everyone has to first think, “How am I going to give the best care to the patients at the most affordable costs?” If you can get your leaders aligned to that, then they’ll make choices that are aligned with what you want to do as an organization. I think leading with your clinicians and getting all your leaders on board so you’re all moving in the same direction. Keeping your patient or your member at the front is really how you get there.
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer
January 15th 2025The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.
Read More